neoHUB is our new 𝐭𝐮𝐦𝐨𝐫 𝐩𝐫𝐨𝐟𝐢𝐥𝐢𝐧𝐠 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦, seamlessly integrating the 𝐈𝐦𝐦𝐮𝐧𝐨𝐄𝐧𝐠𝐢𝐧𝐞 with an 𝐢𝐧𝐭𝐞𝐫𝐚𝐜𝐭𝐢𝐯𝐞, 𝐮𝐬𝐞𝐫-𝐟𝐫𝐢𝐞𝐧𝐝𝐥𝐲 𝐯𝐢𝐬𝐮𝐚𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐢𝐧𝐭𝐞𝐫𝐟𝐚𝐜𝐞. Designed for 𝐢𝐦𝐦𝐮𝐧𝐨-𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐚𝐧𝐝 𝐜𝐥𝐢𝐧𝐢𝐜𝐢𝐚𝐧𝐬, neoHUB allows for the 𝐞𝐱𝐩𝐥𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐤𝐞𝐲 𝐭𝐮𝐦𝐨𝐫 𝐜𝐡𝐚𝐫𝐚𝐜𝐭𝐞𝐫𝐢𝐬𝐭𝐢𝐜𝐬, helping to drive 𝐝𝐚𝐭𝐚-𝐝𝐫𝐢𝐯𝐞𝐧 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧-𝐦𝐚𝐤𝐢𝐧𝐠.
🔬 𝐖𝐡𝐚𝐭 𝐜𝐚𝐧 𝐲𝐨𝐮 𝐞𝐱𝐩𝐥𝐨𝐫𝐞 𝐰𝐢𝐭𝐡 𝐧𝐞𝐨𝐇𝐔𝐁?
▪️ 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰 𝐏𝐫𝐨𝐟𝐢𝐥𝐞 – Summarizes key tumor-specific genomic alterations
▪️ 𝐍𝐞𝐨𝐚𝐧𝐭𝐢𝐠𝐞𝐧 𝐏𝐫𝐨𝐟𝐢𝐥𝐞 – Explore MHCI & MHCII neoantigens with scoring and ranking
▪️ 𝐕𝐚𝐫𝐢𝐚𝐧𝐭 𝐏𝐫𝐨𝐟𝐢𝐥𝐞– Analyze detected SNVs, indels, gene fusions, neoisoforms, and transposable elements
▪️ 𝐄𝐱𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐏𝐫𝐨𝐟𝐢𝐥𝐞 – Compare tumor expression with reference datasets (GTEx & TCGA)
▪️ 𝐇𝐋𝐀 𝐏𝐫𝐨𝐟𝐢𝐥𝐞 – Review HLA typing results and MHC gene expression patterns
▪️ 𝐈𝐦𝐦𝐮𝐧𝐞 𝐏𝐫𝐨𝐟𝐢𝐥𝐞 – Examine tumor microenvironment (TME) composition, including immune cell deconvolution results
💡 𝐖𝐡𝐲 𝐧𝐞𝐨𝐇𝐔𝐁?
✅ 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 – Integrates multiple layers of sequencing data for a holistic view of tumor profiling.
✅ 𝐔𝐬𝐞𝐫-𝐅𝐫𝐢𝐞𝐧𝐝𝐥𝐲 𝐕𝐢𝐬𝐮𝐚𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧𝐬 – Offers intuitive and interactive tools to explore complex data with ease.
✅ 𝐓𝐚𝐢𝐥𝐨𝐫𝐞𝐝 𝐟𝐨𝐫 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 – Designed for immuno-oncology researchers, oncologists, and pathology labs to enhance decision-making.
🔗 Learn more at neohub.myneotx.com or reach out for a full demo!
The launch of neoHUB
19 February 2025
